8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.

Arendash GW, Mori T, Dorsey M, Gonzalez R, Tajiri N, Borlongan C

Bioeffects Seen

Authors not listed · 2012

Share:

Pulsed 918 MHz EMF exposure reversed advanced Alzheimer's brain pathology in elderly mice without causing brain heating, challenging assumptions about EMF effects.

Plain English Summary

Summary written for general audiences

Researchers treated elderly Alzheimer's mice with daily pulsed electromagnetic field exposure (918 MHz, similar to cell phone frequencies) for two months. The treatment reversed advanced beta-amyloid plaque buildup in the brain and improved certain memory functions, without causing brain heating. These findings suggest EMF treatment might potentially help combat Alzheimer's disease progression.

Why This Matters

This study turns conventional EMF concerns on their head, demonstrating that specific electromagnetic frequencies might actually provide therapeutic benefit for neurodegenerative disease. The science shows that two months of daily EMF exposure at 918 MHz (within the frequency range of GSM cell phones) not only halted but reversed advanced Alzheimer's pathology in very old mice, reducing the toxic protein deposits that characterize the disease.

What makes this particularly significant is that it addresses the brain heating concern directly. The researchers confirmed no appreciable brain temperature increases during treatment, meaning the cognitive benefits occurred through biological mechanisms, not thermal effects. The exposure levels (0.25-1.05 W/kg) are comparable to typical cell phone use. This doesn't mean your phone prevents Alzheimer's, but it demonstrates that EMF biological effects are far more complex than simple heating. The research underscores why we need nuanced EMF policy that distinguishes between harmful chronic low-level exposure and potentially therapeutic targeted applications, rather than blanket dismissals of all EMF biological effects.

Exposure Information

A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 2.4 GHz, 50 Hz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 2.4 GHz, 50 HzCell phones~1 GHzWiFi2.4 GHz5G mm28 GHzLogarithmic scale

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2012). Arendash GW, Mori T, Dorsey M, Gonzalez R, Tajiri N, Borlongan C.
Show BibTeX
@article{arendash_gw_mori_t_dorsey_m_gonzalez_r_tajiri_n_borlongan_c_ce3145,
  author = {Unknown},
  title = {Arendash GW, Mori T, Dorsey M, Gonzalez R, Tajiri N, Borlongan C},
  year = {2012},
  doi = {10.1371/journal.pone.0035751},
  
}

Quick Questions About This Study

This study showed that daily electromagnetic treatment at 918 MHz reversed advanced beta-amyloid protein deposits in the brains of very old Alzheimer's mice over two months. The mice also showed improved memory function in certain tests. These results demonstrate therapeutic potential, though human applications require further research.
The researchers used 918 MHz pulsed and modulated electromagnetic fields, which falls within the GSM cell phone frequency range. The specific absorption rate ranged from 0.25 to 1.05 watts per kilogram, comparable to typical mobile phone exposure levels during use.
No. Researchers measured both body and brain temperature throughout the treatment period and found no appreciable increases in brain temperature during EMF exposure. This confirms the cognitive and neuropathological benefits occurred through biological mechanisms rather than thermal heating effects.
The very old mice (21 to 27 months, equivalent to late elderly in humans) received daily electromagnetic field treatment for two months. Previous research by the same team showed even longer treatment periods of six months or more provided cognitive protection and benefits.
Beta-amyloid is a toxic protein that forms sticky plaques in the brains of Alzheimer's patients, damaging neurons and causing cognitive decline. This study showed EMF treatment reversed the aggregation and deposition of these plaques, addressing a primary pathological feature of Alzheimer's disease.